PAG
NBRV

Private Advisor Group’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Private Advisor Group’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-16
Closed -$3K – 3875
2020
Q2 		$3K Buy
+16
New +$2.67K ﹤0.01% 3515

Other funds holding NBRV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
VFA
Values First Advisors Gray, Tennessee $219M AUM 33.35% 1-Year Est. Return

Private Advisor Group's NBRV Position: Q3 2020 in Review

Private Advisor Group sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q3 2020, closing a stake of 16 shares — an estimated $3K sold.

Private Advisor Group first reported a position in NBRV in Q2 2020 and held it in 1 quarter. The position peaked at $3K in Q2 2020. 49 funds tracked by Wall St. Rank hold NBRV as of Q3 2020.

  • Private Advisor Group reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q3 2020 after selling out during the quarter.
  • Private Advisor Group sold 16 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q3 2020, an estimated $3K.
  • Private Advisor Group first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q2 2020 and held it in 1 quarter.
  • Private Advisor Group's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $3K in Q2 2020.
  • 49 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.